These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11211675)

  • 1. Protection of human subjects: turbulent times.
    Sharts-Hopko NC
    J Assoc Nurses AIDS Care; 2001; 12(1):83-6. PubMed ID: 11211675
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of human research subjects: proposed rule.
    Fed Regist; 1979 Aug; 44(158):47687-729. PubMed ID: 10242808
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Nov; 43(231):56173-98. PubMed ID: 10239683
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of human subjects in experimentation. Institutional review boards: purposes, protocols, legal responsibilities.
    Knepper JD
    J Am Med Rec Assoc (1980); 1982 Oct; 53(5):97-101. PubMed ID: 10298700
    [No Abstract]   [Full Text] [Related]  

  • 5. Research activities which may be reviewed through expedited review procedures set forth in HHS regulations for protection of human research subjects--Department of Health and Human Services. Notice.
    Fed Regist; 1981 Jan; 46(16 Pt 2):8392. PubMed ID: 10249933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final regulations amending basic HHS policy for the protection of human research subjects--Department of Health and Human Services. Final rule.
    Fed Regist; 1981 Jan; 46(16 Pt 2):8366-91. PubMed ID: 10249932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of human subjects research: options available to the Institutional Review Board.
    Novak R
    Grants Mag; 1983 Dec; 6(4):225-31. PubMed ID: 10267354
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human subject protection in clinical trials.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):19-23. PubMed ID: 11363958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontherapeutic research on subjects unable to grant consent.
    Frank S; Agich GJ
    Clin Res; 1985 Oct; 33(4):459-64. PubMed ID: 4053504
    [No Abstract]   [Full Text] [Related]  

  • 11. Poor statistical design in research on humans: the role of committees on human research.
    Giammona M; Glantz SA
    Clin Res; 1983 Dec; 31(5):572-8. PubMed ID: 6667598
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in human subject protection.
    Nightingale SL
    Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016
    [No Abstract]   [Full Text] [Related]  

  • 13. Innovative medical therapies: between practice and research.
    Lind SE
    Clin Res; 1988 Oct; 36(6):546-51. PubMed ID: 3180683
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lesson from Melos.
    Owen JA
    Hosp Formul; 1979 Feb; 14(2):127. PubMed ID: 10240142
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with boards and commissions concerned with research ethics in the United States.
    McCarthy CR
    Prog Clin Biol Res; 1983; 128():111-22. PubMed ID: 6634724
    [No Abstract]   [Full Text] [Related]  

  • 17. Guide to decision-making in institutional review of proposals for human experimentation: commentary.
    Rosensaft J
    Man Med; 1978; 3(3):213-20. PubMed ID: 10316738
    [No Abstract]   [Full Text] [Related]  

  • 18. Human experimentation: issues before the hospital administrator.
    Wielk CA
    Hosp Health Serv Adm; 1977; 22(3):4-25. PubMed ID: 12085914
    [No Abstract]   [Full Text] [Related]  

  • 19. Remodelling IRBs.
    Silberner J
    Hastings Cent Rep; 1998; 28(4):5. PubMed ID: 9762532
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. Notice.
    Fed Regist; 1998 Nov; 63(216 Pt 1):60353-6. PubMed ID: 10187395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.